• FDA proposed expanding the sunscreen active ingredient list to include bemotrizinol.
• The Federal Register notice says the proposed order would add bemotrizinol at concentrations up to 6 percent if finalized.
• FDA said a final order would be needed before the ingredient is added to the over-the-counter monograph.
• It remains unclear whether FDA will finalize the proposed order.
• It is not yet clear when products containing bemotrizinol could appear widely on U.S. shelves.

A shopper standing in the sunscreen aisle before a summer weekend may see dozens of bottles, sprays and sticks. Behind those familiar shelves is a slower-moving question: which active ingredients are allowed in over-the-counter sunscreen sold in the United States?

The Food and Drug Administration has proposed adding bemotrizinol to the list of allowed over-the-counter sunscreen active ingredients. If finalized, the change could eventually give manufacturers another approved option for sunscreen products in the U.S. market.

The key word is eventually. The proposal does not mean new products will appear on shelves immediately, and it does not mean the ingredient is already part of the over-the-counter sunscreen monograph. FDA said a final order would be needed before bemotrizinol is added.

What the FDA Proposed

FDA's proposal concerns the active ingredient list for over-the-counter sunscreen drug products. The Federal Register notice says the proposed order would add bemotrizinol at concentrations up to 6 percent if the order is finalized.

That matters because sunscreen is regulated differently from a normal cosmetic product. The active ingredients are tied to sun protection claims, and changes to the allowed list move through a formal process rather than appearing on shelves simply because a company wants to use a new filter.

For consumers, the immediate takeaway is modest but real: the agency has opened the door to a possible ingredient update. It has not yet completed the step that would put bemotrizinol into the monograph.

Why Sunscreen Ingredients Matter

Sunscreen ingredients affect more than the fine print on a bottle. They can influence how a product feels on skin, how it is formulated and what kind of sun protection manufacturers can try to build into future products.

That is why ingredient updates draw attention from consumers, dermatology groups, manufacturers and public health officials. A new allowed filter could eventually give companies another tool when developing sunscreens, though the exact products and claims would depend on how manufacturers formulate and market them.

The proposal should not be read as medical advice or as a reason for consumers to stop using current sunscreen products. It is a regulatory step about what may be allowed in future over-the-counter sunscreen products if the process is finalized.

Why Shelves Will Not Change Overnight

Even if FDA finalizes the proposed order, the change would still have to move from regulation to real products. Manufacturers would need to decide whether to use bemotrizinol, develop formulas, prepare packaging and bring products through normal commercial channels.

That means shoppers should not expect the sunscreen aisle to transform immediately. A final order would create the regulatory path, but product development and distribution would still take time.

It also remains unclear how widely manufacturers would use the ingredient if approved. Some companies may move quickly. Others may wait, test consumer demand or focus on existing formulas.

What Remains Unclear

The central uncertainty is whether FDA will finalize the proposed order. Until that happens, bemotrizinol is not added to the over-the-counter sunscreen monograph through this process.

It is also unclear when products containing bemotrizinol could appear widely on U.S. shelves, how manufacturers would formulate those products, and how they would market them to consumers.

Those unknowns are important because regulatory approval is only one step. The consumer experience depends on what companies actually make, how stores stock it and whether shoppers understand what has changed.

What Consumers Should Watch

The next step to watch is FDA's final order process. If the agency finalizes the proposal, manufacturers and retailers may begin signaling how they plan to use the ingredient in future sunscreen products.

For now, the sunscreen aisle has not changed. But FDA's proposal shows why that aisle may not stay frozen forever. The practical story is not a new bottle on the shelf today; it is a possible opening for more sunscreen options later.

Reporting note: Reporting draws on U.S. Food and Drug Administration materials, the Federal Register notice, consumer health context, and reviewed background materials. This article was produced with AI-assisted research and reviewed by an editor before publication.

You Might Also Like